Medical News

RSS

Venomtech announces new drug development collaboration with Charles River

Venomtech is collaborating with Charles River Laboratories, International Inc. to help drug developers explore venom-derived compounds for a wide range of therapeutic targets.

12 Apr 2022

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Heart complications are uncommon, yet treatable for children and young adults after COVID-19 disease or SARS-CoV-2 infection, according to a new scientific statement from the American Heart Association that details what has been learned about how to treat, manage and even prevent cardiovascular complications from the SARS-CoV-2 virus in youth.

12 Apr 2022

Thousands more vulnerable patients are eligible to receive the UK’s second antiviral for COVID-19

Thousands more vulnerable people in England are now eligible to receive the UK's second oral antiviral treatment for Covid.

12 Apr 2022

Study identifies risk factors for severe COVID-19 in hospitalized children in Canada

Researchers evaluated the risk factors for severe COVID-19 among hospitalized children in Canada.

12 Apr 2022

Dog owners' feeding habits and the impact of FDA hygiene protocols on dog food dish contamination

A survey has recently been conducted by the North Carolina State University, USA, to evaluate the pet food and dish handling habits of pet owners and their impact on bacterial contamination.

12 Apr 2022

Researchers elucidate how ovarian tumors defy immunotherapy

Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators at La Jolla Institute for Immunology and elsewhere, have further elucidated how ovarian cancer tumors defy immunotherapy, identifying new molecular targets that might boost immune response.

12 Apr 2022

Early COVID-19 reinfections possible within 60 days of initial infection

Researchers reported that COVID-19 reinfections could occur within 60 days of the initial infection.

12 Apr 2022

Study finds efficacy of SARS-CoV-2 vaccines reported in Phase 3 trials declines as pandemic prevalence at trial sites increases

A recent study published in PLoS ONE assessed the association of the prevalence of the COVID-19 pandemic with vaccine efficacy.

12 Apr 2022

Impact of face masks on COVID-19 incidence in children in Finland

A new study assessed the impact of face masks on COVID-19 incidence among children aged between 10 and 12 years in Helsinki and Turku.

12 Apr 2022

SARS-CoV-2 control measures and vaccination reduce infection risk for food workers

Researchers investigated the impact of control measures and vaccination to protect food production workers from SARS-CoV-2 infection.

12 Apr 2022

Epidemiologic characteristics of SARS-CoV-2 Omicron and Delta variant infection cases in Cantabria, Spain

Researchers performed a comparative assessment of the key epidemiological characteristics such as secondary attack rates, transmission, serial interval, and incubation period of SARS-CoV-2 infections by the Omicron and Delta variants.

12 Apr 2022

Exploring vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants in adolescents

A new study assessed the effectiveness of the BNT162b2 SARS-CoV-2 vaccine against Delta and Omicron variants in adolescents.

12 Apr 2022

Novel Hendra virus variant detected in flying fox urine

Researchers reported on the detection of a novel Hendra virus variant of genotype 2 (HeV-g2) in the urine of grey-headed and black flying foxes in Australia.

12 Apr 2022

Reactor-Ready Filter Lab Reactor for synthesis and filtration in one compact system

Radleys have launched their new Reactor-Ready Filter Lab Reactor which allows synthesis and filtration in a single jacketed vessel setup, ideal for crystallisation, reaction workups and product isolation.

From Radleys 12 Apr 2022

VectorBuilder to expand with $500 million ‘Gene Delivery Research and Manufacturing Campus

VectorBuilder Inc. has announced the construction of a new R&D and manufacturing center in Guangzhou, China.

From VectorBuilder 12 Apr 2022

Insight into the Breast Cancer Landscape with Breast Cancer Now

In this interview, we speak with Dr. Simon Vincent, Director of Research, Support, and Influencing at Breast Cancer Now, about the current landscape of breast cancer.

12 Apr 2022

Colorado moves toward statewide coverage of wastewater surveillance

On a Sunday morning in March 2020, right at the start of the pandemic, an article in Popular Mechanics caught engineer Pieter Van Ry's eye. It had a catchy title: "How Poop Offers Hints About the Spread of Coronavirus."

12 Apr 2022

California sees dramatic decline in child homicide victims. What’s changed?

The stunning climb in homicide rates in recent years in California and big cities across the nation obscures a remarkably good-news trend involving young children: The number of child homicide victims fell dramatically in California over the past decade, the latest death certificate data shows, a pattern mirrored to a lesser extent nationwide.

12 Apr 2022

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

Researchers evaluated the immunogenicity of Pfizer’s BNT162b2 and Moderna’s mRNA-1273 vaccines offered as the fourth dose against SARS-CoV-2.

12 Apr 2022

COVID-19 vaccination during pregnancy not associated with any observable birth defects on ultrasound

In our latest interview, News Medical speaks to Dr. Rachel Ruderman about her current research, which reveals no detectable link on ultrasound scans between COVID-19 vaccination and birth defects.

12 Apr 2022

Medical News

Venomtech announces new drug development collaboration with Charles River

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Thousands more vulnerable patients are eligible to receive the UK’s second antiviral for COVID-19

Study identifies risk factors for severe COVID-19 in hospitalized children in Canada

Dog owners' feeding habits and the impact of FDA hygiene protocols on dog food dish contamination

Researchers elucidate how ovarian tumors defy immunotherapy

Early COVID-19 reinfections possible within 60 days of initial infection

Study finds efficacy of SARS-CoV-2 vaccines reported in Phase 3 trials declines as pandemic prevalence at trial sites increases

Impact of face masks on COVID-19 incidence in children in Finland

SARS-CoV-2 control measures and vaccination reduce infection risk for food workers

Epidemiologic characteristics of SARS-CoV-2 Omicron and Delta variant infection cases in Cantabria, Spain

Exploring vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants in adolescents

Novel Hendra virus variant detected in flying fox urine

Reactor-Ready Filter Lab Reactor for synthesis and filtration in one compact system

VectorBuilder to expand with $500 million ‘Gene Delivery Research and Manufacturing Campus

Insight into the Breast Cancer Landscape with Breast Cancer Now

Colorado moves toward statewide coverage of wastewater surveillance

California sees dramatic decline in child homicide victims. What’s changed?

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

COVID-19 vaccination during pregnancy not associated with any observable birth defects on ultrasound

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News